Currently, the only accurate diagnosis of Alzheimer’s disease is through postmortem analyses after a patient dies, but investigators have now developed a highly sensitive method for quantifying levels of tau protein—a hallmark of the condition—in cerebrospinal fluid surrounding the brain and spinal cord.